In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, Medtronic’s diabetes spinoff, Regeneron’s purchase of 23AndMe, and more.| Forbes
Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as a powerhouse pharmaceutical R&D center.| Forbes
Khosla-backed Gather Health has signed up more than 2,500 patients, the majority on both Medicare and Medicaid, for its primary-care service. With $17 million in new funding, it’s growing fast—and expects to reach breakeven on its four centers this year.| Forbes
